Keyuan Pharmaceutical: CITIC Construction Investment Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Shandong Keyuan Pharmaceutical Co., Ltd.
Shandong Keyuan Pharmaceutical: Announcement regarding the wholly-owned subsidiary applying for project loans from banks with mortgage guarantee provided by the company.
Shandong Keyuan Pharmaceutical: Special report on the use and placement of funds raised during the first half of 2024.
Shandong Keyuan Pharmaceutical: Announcement of the Supervisory Board's resolution.
Shandong Keyuan Pharmaceutical: Summary of Half-Year Report in 2024.
Shandong Keyuan Pharmaceutical: Board of directors resolution announcement.
Shandong Keyuan Pharmaceutical: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
Shandong Keyuan Pharmaceutical: Announcement About Cancellation of Some Raised Funds Special Account.
Shandong Keyuan Pharmaceutical: Half-year report for the year 2024.
Shandong Keyuan Pharmaceutical: Announcement on the resignation of the general manager and the appointment of the general manager
Shandong Keyuan Pharmaceutical: Announcement of Resolutions of the 16th Meeting of the Third Board of Directors
Shandong Keyuan Pharmaceutical: Announcement on the pledge of some of the shares of the controlling shareholder
Keyuan Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice
Keyuan Pharmaceutical: Progress announcement on the use of some idle funds raised and own funds for cash management, maturity redemption, and continued cash management
Keyuan Pharmaceutical: Announcement on the conclusion of the initial public offering of shares and the cancellation of the special account
Keyuan Pharmaceutical: Report for the first quarter of 2024
Keyuan Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Keyuan Pharmaceutical: Deheng Shanghai Law Firm's Testimony on the 2023 Annual General Meeting of Shareholders of Shandong Keyuan Pharmaceutical Co., Ltd.
Keyuan Pharmaceutical: CITIC Construction Investment Securities Co., Ltd.'s 2023 follow-up report on Shandong Keyuan Pharmaceutical Co., Ltd.
Keyuan Pharmaceutical: An indicative announcement on the lifting of the ban and listing and circulation of some restricted shares prior to the initial public offering
No Data